This inventor holds 2 USPTO granted patents. Top assignees: Queensland Institute of Medical Research, Id Biomedical Corporation of Quebec, Mcgill University. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 31 
1 out of 14 
1 out of 570 
Years Active: 2007-2012
Title: Michael Good: Innovator in Immunogenic Agents and Vaccines
Introduction
Michael Good is a prominent inventor based in The Gap, Australia. He has made significant contributions to the field of immunology, particularly in the development of immunogenic agents and vaccines. With a total of two patents to his name, Good's work focuses on combating various pathogens, including those responsible for malaria and group A streptococcal infections.
Latest Patents
Michael Good's latest patents include an immunogenic agent and a pharmaceutical composition designed to target homologous and heterologous pathogens, including Plasmodium species. The immunogenic agent comprises a low dose of an antigenic component from one or more pathogens, along with an agent that enhances the production of IL-12 in animals. This innovative approach aims to reduce infection or improve recovery from infections caused by these pathogens. Additionally, his vaccine compositions utilize a group A streptococcal antigen combined with a proteosome adjuvant, specifically formulated for intranasal administration to induce immune responses effectively.
Career Highlights
Throughout his career, Michael Good has worked with esteemed organizations, including the Queensland Institute of Medical Research and ID Biomedical Corporation of Quebec. His research has significantly advanced the understanding and treatment of infectious diseases, showcasing his dedication to improving public health.
Collaborations
Michael Good has collaborated with notable individuals in his field, including George H. Lowell and George L. White. These partnerships have contributed to the success of his research and the development of innovative solutions in immunology.
Conclusion
Michael Good's contributions to the field of immunology through his patents and collaborations highlight his role as a key innovator in the development of immunogenic agents and vaccines. His work continues to impact the fight against infectious diseases, demonstrating the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile